Compare Summarecon Agung Tbk. (SMRA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summarecon Agung Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Summarecon Agung Tbk. trades at Rp332 (market cap 5.48T, 21M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 2.3× Summarecon Agung Tbk.'s market cap, and Summarecon Agung Tbk. is more actively traded (21M versus 1.41M). Which is the better fit depends on your goals.
| SMRA | TSPC | |
|---|---|---|
Market Cap | 5.48T | 12.36T |
Volume | 21M | 1.41M |
Lot | 209.99K | 14.08K |
Turnover | 6.97B | 3.83B |
Average Price | 332.14 | 2,722.04 |
Value | 6.97B | 3.83B |
Indicative Equilibrium Price | 332 | 2,730 |
Indicative Equilibrium Volume | 19.86K | 2.51K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summarecon Agung Tbk.
PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
